Literature DB >> 6107437

Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA.

J Grove, G Tell, P J Schechter, J Koch-Weser, J M Warter, C Marescaux, L Rumbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6107437     DOI： 10.1016/s0140-6736(80)90318-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children.

Authors:  E Rey; G Pons; M O Richard; F Vauzelle; P D'Athis; C Chiron; O Dulac; D Beaumont; G Olive
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  Plasma and cerebrospinal fluid gamma-aminobutyric acid in neurological disorders.

Authors:  D Schmidt; W Löscher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

3.  Changes in the ERG d-wave with vigabatrin treatment in a pediatric cohort.

Authors:  Rachel Dragas; Carol Westall; Tom Wright
Journal:  Doc Ophthalmol       Date:  2014-07-10       Impact factor: 2.379

4.  Experimental studies of the influence of vigabatrin on the GABA system.

Authors:  L Gram; O M Larsson; A Johnsen; A Schousboe
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.